Notice: This company has been marked as potentially delisted and may not be actively trading. Fusion Pharmaceuticals (FUSN) Insider Trading & Ownership Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestTrends Fusion Pharmaceuticals (NASDAQ:FUSN) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage7.75%Number OfInsiders Buying(Last 3 Years)1Amount OfInsider Buying(Last 3 Years)$90,132.00Number OfInsiders Selling(Last 3 Years)1Amount OfInsider Selling(Last 3 Years)$517,191.81 Get FUSN Insider Trade Alerts Want to know when executives and insiders are buying or selling Fusion Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address FUSN Insider Buying and Selling by Quarter Ad Colonial Metals“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as we wait for Trump's agenda to kick in…>> YES! Send Me My FREE Gold Guide! Fusion Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/11/2022Steven GannonDirectorBuy44,400$2.03$90,132.00 4/27/2022John ValliantCEOSell4,511$6.03$27,201.33 4/25/2022John ValliantCEOSell2,036$6.03$12,277.08 4/20/2022John ValliantCEOSell367$6.02$2,209.34 4/13/2022John ValliantCEOSell11,994$6.41$76,881.54 4/11/2022John ValliantCEOSell2,600$7.37$19,162.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 4/8/2022John ValliantCEOSell826$7.52$6,211.52 4/6/2022John ValliantCEOSell100$7.58$758.00 3/30/2022John ValliantCEOSell300$7.52$2,256.00 3/28/2022John ValliantCEOSell9,600$7.55$72,480.00 3/25/2022John ValliantCEOSell500$7.42$3,710.00 3/23/2022John ValliantCEOSell100$7.50$750.00 3/21/2022John ValliantCEOSell1,500$7.47$11,205.00 3/17/2022John ValliantCEOSell900$7.51$6,759.00 3/7/2022John ValliantCEOSell3,100$6.99$21,669.00 3/4/2022John ValliantCEOSell8,400$7.32$61,488.00 2/28/2022John ValliantCEOSell3,100$7.40$22,940.00 2/24/2022John ValliantCEOSell2,500$7.41$18,525.00 2/22/2022John ValliantCEOSell4,100$7.85$32,185.00 2/17/2022John ValliantCEOSell1,700$7.98$13,566.00 2/15/2022John ValliantCEOSell12,600$8.33$104,958.00 (Data available from 1/1/2013 forward) FUSN Insider Trading Activity - Frequently Asked Questions Who is on Fusion Pharmaceuticals's Insider Roster? The list of insiders at Fusion Pharmaceuticals includes John Valliant, and Steven Gannon. Learn more on insiders at FUSN. What percentage of Fusion Pharmaceuticals stock is owned by insiders? 7.75% of Fusion Pharmaceuticals stock is owned by insiders. Learn more on FUSN's insider holdings. More Insider Trading Tools from MarketBeat Related Companies Y-mAbs Therapeutics Insider Trades MeiraGTx Insider Trades Arcellx Insider Trades ADMA Biologics Insider Trades Krystal Biotech Insider Trades Denali Therapeutics Insider Trades Immunovant Insider Trades CRISPR Therapeutics Insider Trades ImmunityBio Insider Trades Kymera Therapeutics Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Here’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking OnInsiders Are Buying High-Yielding Delek Logistics PartnersInsider Selling is not a Signal to Start Selling Gartner Stock This page (NASDAQ:FUSN) was last updated on 11/12/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Abandons USDStartling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – ...True Gold Republic | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredThis company will win the AI race Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally c...Porter & Company | SponsoredCritical warning from the mountains of CarolinaNvidia CEO Jensen Huang says Big Tech will spend over $1 trillion on data centers. And that still might not...Weiss Ratings | SponsoredCrypto’s FINAL Wealth MomentBitcoin’s final bull market is here. If you missed out on the gains in 2017, or 2021… 2025 stands to be jus...Paradigm Press | SponsoredWhy Trump’s Win Can’t Stop the Coming Crisis - Protect Yourself NowNo matter who sits in the White House over the next four years, a series of events has been triggered that cou...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fusion Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fusion Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
